Inspire Medical’s share dips 0.38% as its neurostimulation tech for sleep apnea steadies; 12% revenue growth, 18% margin, and a 200‑day SMA at $59.45 hint at a potential rebound.
Inspire Medical rises 1.98% on March 21, 2026—trade at $71.34, market cap $2B. Learn why the neuro‑stimulation firm tops the OSA treatment market and peer gains.